Stanford Medicine
M

Pediatric Obesity: Clinical Practice Guidelines and Cardiovascular Risk

By Stanford Medicine FEATURING Michelle Kaplinski
By Stanford Medicine FEATURING Michelle Kaplinski
437 views
January 3, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

04:59
Merck

Clinical and Public Health Importance of Adult Pneumococcal Disease

Related Content

AUTOPLAY
47:11
Houston Methodist Hospital

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
49:21
Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key
17:21
Ilene Fennoy

Obesity and Diabetes in Children

34:49
Scripps Health

Medications for Weight Loss: The New Satiety Hormones

Feat. K. Fujioka
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
18:46
Houston Methodist Hospital

MAFLD: What Is It?

Feat. D. Victor
26:32
Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen
44:41
Norman Lepor

Obesity: New Understanding and Treatments

26:49
Diana Isaacs

Tirzepatide Updates

19:24
National Lipid Association

Do Triglycerides Cause Heart Disease?

Feat. I. Goldberg
19:26
Krista Varady

ADA 2022 Flipping the Metabolic Switch: Intermittent Fasting as a We…

22:00
Canadian Collaborative Research Network

Lessons Learned From the MASALA Study

Feat. A. Kanaya
28:05
Michael Makover

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

22:22
Practical Ways to Achieve Targets in Diabetes Care

Omega-3 Fatty Acids and Cardiovascular Outcomes: Anatomy of a Fish T…

Feat. S. Nissen
05:08
Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

21:06
NYU Langone

Pharmacotherapy for Weight Management: Present and Future

Feat. H. Lofton
06:31
Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

44:43
Jason Fung

Type 2 Diabetes Aetiology and Reversibility

17:54
Keck School of Medicine of USC

Pregnancy Considerations for Patients with Obesity and Postpartum Ma…

Feat. K. Chen, C. T. Nguyen